Eagle Pharmaceuticals CEO Scott Tarriff's 2021 pay falls 32% to $6.5M
Eagle Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: June 15, 2022
Eagle Pharmaceuticals reported fiscal year 2021 executive compensation information on June 15, 2022.
In 2021, five executives at Eagle Pharmaceuticals received on average a compensation package of $2.8M, a 27% decrease compared to previous year.
Average pay of disclosed executives at Eagle Pharmaceuticals
Scott Tarriff, Chief Executive Officer, received $6.5M in total, which decreased by 32% compared to 2020. 66% of Tarriff's compensation, or $4.3M, was in stock awards. Tarriff also received $1.3M in non-equity incentive plan, $816K in salary, as well as $23K in other compensation.
For fiscal year 2021, the median employee pay was $246,233 at Eagle Pharmaceuticals. Therefore, the ratio of Scott Tarriff's pay to the median employee pay was 26 to one.
David Pernock, Chief Operating Officer, received a compensation package of $3M, which decreased by 21% compared to previous year. 41% of the compensation package, or $1.2M, was in other compensation.
Michael Moran, Chief Commercial Officer, earned $1.9M in 2021.
Brian Cahill, Chief Financial Officer, received $1.9M in 2021, which increases by 2% compared to 2020.
Judith Ng-Cashin, Chief Medical Officer, earned $950K in 2021, which is about the same as previous year.
Related executives
You may also like
Source: SEC filing on June 15, 2022.